Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Alzheimers Disease Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Alzheimers Disease Therapeuticsmarket, defines the market attractiveness level of Alzheimers Disease Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Alzheimers Disease Therapeutics industry, describes the types of Alzheimers Disease Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Alzheimers Disease Therapeutics market and the development prospects and opportunities of Alzheimers Disease Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Alzheimers Disease Therapeutics market in Chapter 13.
By Player:
Daiichi Sankyo
Merck
Novartis
F Hoffmann-La Roche
Actavis
Pfizer
Eisai
By Type:
Biomarkers
Cholinesterase Inhibitors
NMDA Receptor Antagonists
By End-User:
Hospitals
Clinics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Alzheimers Disease Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Alzheimers Disease Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Alzheimers Disease Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Alzheimers Disease Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Alzheimers Disease Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Alzheimers Disease Therapeutics Consumption (2017-2022)
-
7.2 United States Alzheimers Disease Therapeutics Consumption (2017-2022)
-
7.3 Europe Alzheimers Disease Therapeutics Consumption (2017-2022)
-
7.4 China Alzheimers Disease Therapeutics Consumption (2017-2022)
-
7.5 Japan Alzheimers Disease Therapeutics Consumption (2017-2022)
-
7.6 India Alzheimers Disease Therapeutics Consumption (2017-2022)
-
7.7 South Korea Alzheimers Disease Therapeutics Consumption (2017-2022)
8 Region and Country-wise Alzheimers Disease Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Alzheimers Disease Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Alzheimers Disease Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Alzheimers Disease Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Alzheimers Disease Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Alzheimers Disease Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Alzheimers Disease Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Alzheimers Disease Therapeutics Consumption Forecast (2022-2028)
9 Global Alzheimers Disease Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Alzheimers Disease Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Biomarkers Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Cholinesterase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global NMDA Receptor Antagonists Consumption and Growth Rate (2017-2022)
-
9.2 Global Alzheimers Disease Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
10 Global Alzheimers Disease Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Alzheimers Disease Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Biomarkers Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Cholinesterase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global NMDA Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Alzheimers Disease Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
11 Global Alzheimers Disease Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Alzheimers Disease Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Alzheimers Disease Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Alzheimers Disease Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Alzheimers Disease Therapeutics Market Competitive Analysis
-
14.1 Daiichi Sankyo
-
14.1.1 Daiichi Sankyo Company Details
-
14.1.2 Daiichi Sankyo Alzheimers Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Daiichi Sankyo Alzheimers Disease Therapeutics Product and Service
-
14.2 Merck
-
14.2.1 Merck Company Details
-
14.2.2 Merck Alzheimers Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck Alzheimers Disease Therapeutics Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Alzheimers Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Alzheimers Disease Therapeutics Product and Service
-
14.4 F Hoffmann-La Roche
-
14.4.1 F Hoffmann-La Roche Company Details
-
14.4.2 F Hoffmann-La Roche Alzheimers Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 F Hoffmann-La Roche Alzheimers Disease Therapeutics Product and Service
-
14.5 Actavis
-
14.5.1 Actavis Company Details
-
14.5.2 Actavis Alzheimers Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Actavis Alzheimers Disease Therapeutics Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Alzheimers Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Alzheimers Disease Therapeutics Product and Service
-
14.7 Eisai
-
14.7.1 Eisai Company Details
-
14.7.2 Eisai Alzheimers Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Eisai Alzheimers Disease Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Alzheimers Disease Therapeutics
-
Figure Alzheimers Disease Therapeutics Picture
-
Table Global Alzheimers Disease Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alzheimers Disease Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alzheimers Disease Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Alzheimers Disease Therapeutics Consumption by Country (2017-2022)
-
Figure United States Alzheimers Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Alzheimers Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Alzheimers Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Alzheimers Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Alzheimers Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Alzheimers Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Alzheimers Disease Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Alzheimers Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Alzheimers Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Alzheimers Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Alzheimers Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Alzheimers Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Alzheimers Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biomarkers Consumption and Growth Rate (2017-2022)
-
Figure Global Cholinesterase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global NMDA Receptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Biomarkers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cholinesterase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NMDA Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Alzheimers Disease Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Alzheimers Disease Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Alzheimers Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Alzheimers Disease Therapeutics Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Alzheimers Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Alzheimers Disease Therapeutics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Alzheimers Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Alzheimers Disease Therapeutics Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Alzheimers Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Alzheimers Disease Therapeutics Product and Service
-
Table Actavis (Foundation Year, Company Profile and etc.)
-
Table Actavis Alzheimers Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actavis Alzheimers Disease Therapeutics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Alzheimers Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Alzheimers Disease Therapeutics Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Alzheimers Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Alzheimers Disease Therapeutics Product and Service
-
